Global Bio Fund logo

Global Bio Fund

Oceania, Auckland, New Zealand, Auckland

Description

Bio seed accelerator fund

Investor Profile

Global Bio Fund has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Oncology.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Global Bio Fund frequently co-invest with?

Inovio Pharmaceuticals
North America, Pennsylvania, United States, Plymouth Meeting
Co-Investments: 1
Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Flerie Invest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

What are some of recent deals done by Global Bio Fund?

Geneos Therapeutics

Plymouth Meeting, Pennsylvania, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AMar 24, 2022
Amount Raised: $17,000,000